User talk: Kashmiri
|Kashmiri is taking a short wikibreak and will be back on Wikipedia soon.|
|This user is busy in real life and may not respond swiftly to queries.|
|This is Kashmiri's talk page, where you can send messages and comments to Kashmiri.|
- 1 Map: Durrani Empire
- 2 WP:PRICE
- 3 A cup of coffee for you!
- 4 File:Royal Society of Chemistry.svg listed for discussion
- 5 SMN
- 6 multiple sclerosis cure report
- 7 Heer Ranjha (1992 film)
- 8 File:ERTMS.svg listed for discussion
- 9 RfC concerning Redirects to Non-free images
- 10 List of Country Calling Codes
Map: Durrani Empire
The map of the empire in the peak time exactly the same as the current international border which is not correct. Also, according to some references, Mashhad was under control of Shahrukh Afshar until the conquer by Qajar Dynasty.    
Says "An article should not include product pricing or availability information unless there is an independent source and a justified reason for the mention."
- @Doc James: What's the justification, other than just giving an estimated annual cost for an uninsured patient in one out of 183 countries of the world? Shall this possible reason apply to other drugs and countries, too? Thanks! — kashmiri TALK 20:54, 14 May 2016 (UTC)
- This ref provide a price range for a bunch of countries http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=SAL01D&s_year=2014&year=2014&str=100%20mcg%2Fdose&desc=Salbutamol&pack=new&frm=INHALER&rte=INH&class_code2=&supplement=&class_name=%28%29%3Cbr%3E
- So we are not talking about a single country but a bunch of countries. Prices for a single medication in a bunch of countries does not vary that much. And price differences between developed countries is usually not that much. (USA is usually most but other countries have laws regarding how high prices can be compared to other countries)
- Linezolid is much more expensive than Septra is all countries. Both are used for MRSA. I regularly see people who come to the ER as the first doctor they saw prescribed a treatment that was more than they could afford and they are looking for a less expensive option. Doc James (talk · contribs · email) 20:58, 14 May 2016 (UTC)
- You wrote about consensus at WT:MED. I checked out the most recent threads on drug pricing but don't see any "consensus".
- https://en.wikipedia.org/wiki/Wikipedia_talk:WikiProject_Medicine/Archive_19#Drug_pricing_reminder – no retail prices!
- https://en.wikipedia.org/wiki/Wikipedia_talk:WikiProject_Medicine/Archive_67#Prices – consensus here is about not adding prices
- https://en.wikipedia.org/wiki/Wikipedia_talk:WikiProject_Medicine/Archive_78#Reliable_sources_for_drug_pricing.3F – consensus: no retail prices
- I see you have been arguing for adding pricing info, but didn't see many takers for this.
- Wholesale drug pricing varies in the range of up to 5x between various developed countries. Retail pricing is irrelevant in many (most?) developed countries as state-funded healthcare results in lack of "retail price" for prescription drugs, moreover consensus is against adding retail pricing. — kashmiri TALK 21:06, 14 May 2016 (UTC)
- Here you have price of septra in India: .
- And here a comparison of ex-factory drug prices in various OECD countries: . As you can see, wholesale price of branded drugs in some countries can be even as little as 20% of the corresponding US price. Adding US prices to Wikipedia is at best irrelevant for the majority of the world, and misleading at worst. — kashmiri TALK 21:21, 14 May 2016 (UTC)
- Once again a 5X difference is tiny. Different drugs vary in prince by more than 100,000,000 fold. Doc James (talk · contribs · email) 22:16, 14 May 2016 (UTC)
- For example the new hep C treatments cost from $20,000 to $100,000 for a course depending on which option is chosen and were in the world it is gotten. Somebody pays. If you get it covered it would likely increase your appreciation I would hope. If not it will be a tough choice for many. Doc James (talk · contribs · email) 22:26, 14 May 2016 (UTC)
- @Doc James: Correct. So, remind me again please why you insist on having "average price in the US" on Wikipedia? Why not average drug price say, in India (1.2 billion people)? Or in the EU (0.5 billion)? Personally, I consider US pricing information as irrelevant for the majority of readers who have health insurance, and misleading for the rest. It also appears that the WT:MED consensus was not to include retail pricing in articles. Will you object if I remove pricing information from salbutamol? FYI, the annual cost of oral salbutamol 4mg tds in India is around $15. Regards, — kashmiri TALK 15:58, 15 May 2016 (UTC)
- You wrote about consensus at WT:MED. I checked out the most recent threads on drug pricing but don't see any "consensus".
- The US often has some of the more expensive pricing. Therefore prices in most countries is somewhere between the global price listed and the US price.
- Canada partly bases our prices on prices in the USA.
- The USA makes up a significant portion of the English speaking world.
- The US makes up a significant portion of our EN readership, therefore for prevalence I often include the prevalence of diseases in the US (Canada, Australia, India(when available), and the UK)
- Oral salbutamol in India? Interesting. You will notice that $15 is between $1.12 and $50 therefore our pricing info IS useful for people in India.
- India by the way can buy pharmaceuticals at these prices http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=SAL01D&s_year=2014&year=2014&str=100%20mcg%2Fdose&desc=Salbutamol&pack=new&frm=INHALER&rte=INH&class_code2=&supplement=&class_name=%28%29%3Cbr%3E
- Yes I would object to you removing it. Doc James (talk · contribs · email) 19:58, 15 May 2016 (UTC)
- @Doc James: What about you going AGAINST consensus with your adding retail drug prices all over? Is that not a valid reason for removal? — kashmiri TALK 21:04, 15 May 2016 (UTC)
- As for the rest, I suggest you dig more into the subject of drug pricing across the world. Regards, — kashmiri TALK 21:04, 15 May 2016 (UTC)
A cup of coffee for you!
- Dear Bluerasberry, I am genuinely moved by your message. Thank you for the disclosure. I am also linked to two nonprofit organisations which advocate for access to medicines, although in our case - rare diseases - we also have to consider higher development costs and smaller "customer population", so we cannot always press for lower prices. Also, I am a volunteer, not an employee. That said, in no way am I an expert on drug pricing, and I know the matter primarily through the prism of drug pricing in rare diseases (excellent EURORDIS conferences!).
- As far as I recall, mean price for a given drug varies greatly across EU, with some payers (usually, national healthcare providers) agreeing to pay even 2–2.5 times more than the prices charged to other EU payers. Details of each contract are of course kept confidential, but some interesting statistics are available with EURORDIS and the European Commission. In the European context, it is quite hard to establish a "wholesale price" even for a single drug – will "wholesale" be the price paid by the government, or one paid by pharmacies? Or by private hospitals? Here, someone trying to propose a "globally true wholesale price", and even more, a "global retail price", borders absurdity in my view. But I don't know, sometimes decisions of the Wikipedia community are more driven by "let's include everything we can come up with" than by common sense. Best regards, — kashmiri TALK 16:11, 16 May 2016 (UTC)
File:Royal Society of Chemistry.svg listed for discussion
A file that you uploaded or altered, File:Royal Society of Chemistry.svg, has been listed at Wikipedia:Files for discussion. Please see the discussion to see why it has been listed (you may have to search for the title of the image to find its entry). Feel free to add your opinion on the matter below the nomination. Thank you. Stefan2 (talk) 10:45, 17 May 2016 (UTC)
Hi kashmiri re the moves I made to SMN (I only moved it twice) - I only came across the page when I was looking for info on 'gems' and there seemed to be a lot of confusion around. I was only trying to clear some of this and the references I found and cited used 'of' in the phrasing - also used in the infoboxes of SMN1 and 2 - the refs I've seen also refer to 'motor neurons protein'. It doesn't matter to me which is used but it would help if there was a consistency in the pages. And if its more usual to use the gene I would suggest as already suggested on talk page that SMN be merged to SMN1. Thanks --Iztwoz (talk) 23:23, 27 May 2016 (UTC)
- Hi @Iztwoz: Yes it may be confusing. The literature has not yet standardised the name - SMN1's function was only described in 1995. That paper consistently uses "survival motor neuron". On the other hand, OMIM has consistently "survival of motor neuron". I am fine with either.
- As to whether to keep SMN under SMN1, I am not that sure, because SMN is also a product of SMN2 gene – there are even a few therapies under development that aim to increase coding of SMN from the SMN2 gene. I am inclined to keep the SMN article separate, the way it is, at least for the time being. Regards, — kashmiri TALK 23:53, 27 May 2016 (UTC)
- Fine with me! — kashmiri TALK 00:04, 28 May 2016 (UTC)
multiple sclerosis cure report
Hi Kashmiri, I have just read your concern that I may have cited a press report in its entirety. I did not. It is just an extract of the press report, and moreover I have cited the source in agreement with copyright law. If you are able to access and read the Cell Report article and contribute to Wikipedia, I would appreciate it. Alternatively, please remove the editing block so that someone else can do so.188.8.131.52 (talk) 16:17, 1 June 2016 (UTC)
- Hi, the problem is even the Cell Report article, which sure is compliant with WP:MEDRS, is a WP:PRIMARY source whereas there is strong preference for WP:SECONDARY sources for medicine-related articles. Reporting results of preclinical studies, and even pilot clinical trials, is also discouraged because the obtained results, even though published, cannot be considered conclusive for efficacy. Results of completed efficacy trials can be published, I believe, although I would still need to locate the actual policy. — kashmiri TALK 16:22, 1 June 2016 (UTC)
- Thanks for trying. Press releases are usually released a couple of days before the real article is out. So please try again in a few days. And for convenience, let us continue any further discussion on the MS Talk page, where Doc James has added his comments.184.108.40.206 (talk) 16:32, 1 June 2016 (UTC)
- You have to quote reliable sources.
- You have to know something about the film, which you don't.
- @Xx236: You don't have to quote sources in a stub. Redirecting to director breaks disambig page because it no longer points to where it is supposed to. — kashmiri TALK 11:13, 14 June 2016 (UTC)
- If a stub has little verifiable information, or if its subject has no apparent notability, it may be deleted or be merged into another relevant article.
- I'm editing Hindu movie pages and you are complaining. Why don't you write good pages?Xx236 (talk) 12:03, 14 June 2016 (UTC)
File:ERTMS.svg listed for discussion
A file that you uploaded or altered, File:ERTMS.svg, has been listed at Wikipedia:Files for discussion. Please see the discussion to see why it has been listed (you may have to search for the title of the image to find its entry). Feel free to add your opinion on the matter below the nomination. Thank you. Sfan00 IMG (talk) 11:06, 16 June 2016 (UTC)
RfC concerning Redirects to Non-free images
Would you like to start one, (given comments you left on my talk page)?
- @Sfan00 IMG: Good idea - the question is, I believe, whether we should add "(logo)" and possibly expand acronyms across Wikipedia, or leave the file names as they are, possibly consistent with the main article title. I am afraid I will have little time for Wikipedia until mid-next week, as a good RfC requires explanation and justification, so feel free to go ahead. Thanks for asking, appreciated! — kashmiri TALK 10:31, 17 June 2016 (UTC)
- I was asking you to draft something possibly, so politeness would be for me to let you do that, rather than drafting my own somewhat inferior proposal. Sfan00 IMG (talk) 10:33, 17 June 2016 (UTC)